About the Laboratroy of Inflammation and Vaccines (LIV)
Welcome to our cutting-edge research facility located in the heart of Shenzhen, China. Our laboratory specializes in the study of inflammation and the development of vaccines to prevent diseases caused by inflammation.
Inflammation is a natural response of the body to protect against infections, injuries and other harmful stimuli. However, when it becomes chronic, it can lead to serious health problems such as cancer, heart disease, and autoimmune disorders. Our team of experts is dedicated to understanding the underlying mechanisms of inflammation and developing new treatments to address this growing health concern.
At our laboratory, we use the latest technologies and techniques to perform groundbreaking research in the field of inflammation and vaccine development. Our state-of-the-art facilities and equipment allow us to make rapid progress in our work, and we are committed to sharing our findings with the scientific community and the public to improve human health.
If you are interested in learning more about our laboratory, our research, or our services, please do not hesitate to contact us. We would be happy to answer any questions you may have and provide you with additional information.
Join us in our mission to improve human health through the study of inflammation and vaccine development.
Characteristics: Multidisciplinary research for the treatment of inflammatory and infectious diseases
The aim of the Laboratory of Inflammation and Vaccines is to develop novel immunotherapeutic drugs and vaccines against inflammatory and infectious diseases. This is done by addressing 4 research topics:
A. Immune mechanisms in inflammatory and infectious diseases
B. Vaccines and monoclonal antibodies
C. Adjuvants and intelligent nanocarriers
D. Diagnostic and predictive immuno-safety assessment
A strong translational effort will be made for transferring the research outputs into new preventive and therapeutic strategies.

LIV Research Area
Immune mechanisms in inflammatory and infectious diseases
Vaccines and monoclonal antibodies
Adjuvants and intellligent nanocarriers
Diagnostic and predictive immuno-safety assessment